⌘K

Login Start Free

Home/Filings/4/0000899243-21-025000

4//SEC Filing

Biondi Paul 4

Accession 0000899243-21-025000

CIK 0001609809other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:31 PM ET

Size

5.4 KB

Accession

0000899243-21-025000

Insider Transaction Report

Form 4

Period: 2021-06-16

Seres Therapeutics, Inc.MCRB

Director

Transactions

Award
Stock Option (right to buy)
2021-06-16+23,000→ 23,000 total
Exercise: $19.74Exp: 2031-06-15→ Common Stock (23,000 underlying)

Footnotes (1)

[F1]The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1

filerCIK 0001744508

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 4:31 PM ET
Size: 5.4 KB

View on SEC.gov